GOLDMAN SACHS GROUP INC - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 30 filers reported holding QUALIGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$123,00024,7680.00%
Other shareholders

There were no reported owners of QUALIGEN THERAPEUTICS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of QUALIGEN THERAPEUTICS INC shareholders